ID   LaNCE hiPSC-34
AC   CVCL_WR87
SY   hiPSC-34; LANCEi009-A
DR   hPSCreg; LANCEi009-A
DR   Wikidata; Q95981244
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D18S51: 12,19
ST   D19S433: 14
ST   D21S11: 29,33.2
ST   D2S1338: 17
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   D8S1179: 14
ST   FGA: 21,22
ST   TH01: 8,9.3
ST   TPOX: 10,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
RX   PubMed=29433076; DOI=10.1016/j.scr.2018.01.030;
RA   Sarafian R.D., Morato-Marques M., Borsoi J., Pereira L.V.;
RT   "Monitoring cell line identity in collections of human induced
RT   pluripotent stem cells.";
RL   Stem Cell Res. 28:66-70(2018).
//